title: Retrobulbar chlorpromazine in management of painful eye in blind or low vision patients.
abstract: OBJECTIVE
  To evaluate the results of applying retrobulbar chlorpromazine in the management of patients with painful blind eyes or with very poor vision.
  
  
  METHODS
  A retrospective, descriptive review was carried out on the medical records of 33 patients who were treated with a retrobulbar injection of chlorpromazine (25mg) for the management of painful blind eyes in Centro Oftalmológico Virgilio Galvis.
  
  
  RESULTS
  Pain control was achieved in 90% of cases (with mean follow-up of 2.1 years). The mean intraocular pressure decreased by 37%. In 7 out of 12 eyes that maintained residual vision, loss of some degree of vision was acknowledged. One patient required an additional cyclodestructive procedure, another one required an absolute alcohol injection, and in an additional case evisceration surgery was necessary to achieve pain control. No serious complications were noted with this therapy.
  
  
  CONCLUSIONS
  Retrobulbar injection of chlorpromazine is a valid option in painful, blind eye cases (or with very poor vision) with a poor visual prognosis.
authors.affiliation: Departamento de Oftalmología, Fundación Oftalmológica de Santander (FOSCAL), Bucaramanga, Santander, Colombia; Centro Oftalmológico Virgilio Galvis, Floridablanca, Santander, Colombia. Electronic address: docaortizoft@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Ortiz
authors.affiliation: Departamento de Oftalmología, Fundación Oftalmológica de Santander (FOSCAL), Bucaramanga, Santander, Colombia; Centro Oftalmológico Virgilio Galvis, Floridablanca, Santander, Colombia; Universidad Autónoma de Bucaramanga (UNAB), Bucaramanga, Santander, Colombia.
authors.forename: V
authors.initials: V
authors.lastname: Galvis
authors.affiliation: Departamento de Oftalmología, Fundación Oftalmológica de Santander (FOSCAL), Bucaramanga, Santander, Colombia; Centro Oftalmológico Virgilio Galvis, Floridablanca, Santander, Colombia; Universidad Autónoma de Bucaramanga (UNAB), Bucaramanga, Santander, Colombia.
authors.forename: A
authors.initials: A
authors.lastname: Tello
authors.affiliation: Departamento de Oftalmología, Fundación Oftalmológica de Santander (FOSCAL), Bucaramanga, Santander, Colombia.
authors.forename: J J
authors.initials: JJ
authors.lastname: Miro-Quesada
authors.affiliation: Centro Oftalmológico Virgilio Galvis, Floridablanca, Santander, Colombia.
authors.forename: R
authors.initials: R
authors.lastname: Barrera
authors.affiliation: Universidad Autónoma de Bucaramanga (UNAB), Bucaramanga, Santander, Colombia.
authors.forename: M
authors.initials: M
authors.lastname: Ochoa
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001766:Blindness / Q000150:complications*; D002648:Child; D002746:Chlorpromazine / Q000008:administration & dosage*; D058447:Eye Pain / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D009900:Optic Nerve; D012189:Retrospective Studies; D015354:Vision, Low / Q000150:complications*; D055815:Young Adult
chemical_list: D002746:Chlorpromazine
keywords: Baja visión; Blindness; Ceguera; Chlorpromazine; Clorpromazina; Dolor intratable; Dolor ocular; Eye pain; Intractable pain; Low visión